Cidara Therapeutics, Inc.·4

Sep 18, 7:36 PM ET

Johnson Brady 4

4 · Cidara Therapeutics, Inc. · Filed Sep 18, 2018

Insider Transaction Report

Form 4
Period: 2018-09-14
Johnson Brady
Dir. of Finance & Controller
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-09-14+4,0004,000 total
    Exercise: $4.25Exp: 2028-09-13Common Stock (4,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of September 14, 2018 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION